Join G2G Consulting for insights into successfully submitting an abstract for the annual MHSRS conference (due February 16, 2022), plus tips on navigating and engaging effectively with the Defense Health Agency, Futures Command, USAMRDC, WRAIR, USAISR and other potential collaborators within government.

Kim Murnieks, Director of the Office of Budget and Management for Governor Mike DeWine to share insights on this year’s budget process and answer your questions. She will be joined by Will Tartar of the Center for Community Solutions, and experts from the G2G team, who will share insights on how best to navigate the process and access Capital Budget dollars for local projects.

Are you a current or aspiring inventor or entrepreneur? Would you like to learn from successful innovators and subject matter experts about keys to success and vital resources? If so, register early for the February 17 Black Innovation and Entrepreneurship program hosted by the United States Patent and Trademark Office (USPTO).

Every third Friday of the month, G2G hosts this monthly GBG Reporting Service Webinars to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session.

Today, healthcare innovation centers on advancing breakthrough treatments to improve patient outcomes. Focused Ultrasound is a revolutionary, noninvasive therapy that can treat multiple diseases and has the potential to address many more with further R&D funding. Join us to learn how, for many patients, this noninvasive, non-pharmacological treatment is a significant improvement over conventional therapies and reduces overall costs. This briefing will educate about the established benefits of focused ultrasound, its potential in other areas of healthcare, and the value of additional research investment to advance this field of medicine.

Are you a current or aspiring inventor or entrepreneur? Would you like to learn from successful innovators and subject matter experts about keys to success? If so, register early for the February 24 Black Innovation and Entrepreneurship program hosted by the United States Patent and Trademark Office (USPTO).

Every third Friday of the month, G2G hosts this online event to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities, such as grants and BAAs that could accelerate company growth. We will share insights from our research and provide some Q&A during the first half hour. We then take a deeper dive on non-dilutive federal government funding sources and related priorities with consultation during the second half hour for our customers.

In the United States, the CDC estimates that 100,000 Americans have sickle cell disease (SCD). About 90% of people with SCD are of African descent. SCD also occurs in Hispanic, South Asian, Middle Eastern, and Southern European ancestry. A panel of experts, moderated by BioOhio’s Eddie Pauline, will discuss current programs that assist patients and families, as well as how Ohio’s hospital and health systems are contributing to SCD research and advancements in treatment.

For patients on Medicare, the majority of whom are over age 65, time matters. However, newly published research from the Stanford Byers Center for Biodesign shows that patients can wait up to 5 years after FDA authorization to access new medical technologies. Instead, a well-designed transitional coverage program could greatly accelerate patients’ access to care, while reducing the overall cost burden on our healthcare system. This program would also encourage innovation in areas of critically important unmet clinical needs. The Duke-Margolis Center for Health Policy has recommended the addition of several key elements to a transitional coverage pathway, highlighting the need for early engagement between stakeholders to inform and guide evidence development and appropriate use of novel technologies. Please join us to explore these findings and hear the perspectives of physicians, innovators and CMS stakeholders on this important initiative to advance patient care.

The Conference on Innovations in Climate Resilience, presented by Battelle in collaboration with DOE National Laboratories, offers a curated technical program with invited keynote presentations, platform and lightning talks and a poster reception. We’re expecting an audience of government leaders, entrepreneurs and innovators to explore breakthroughs in technology, science, policy and infrastructure that will help mitigate the threats to our environment, health, communities, national security and economic well-being from a changing climate.